BIOA — BioAge Labs, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1709941 ·
Last close
$5.10
Market Cap
$234.35M
52W High
$25.95
52W Low
$4.81
ADV30
727,499
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 298,000 — -37,411,000 -33,504,000 367,648,000 52,666,000 21,202,000
Jun 2026 2,451,000 — -29,333,000 -26,097,000 396,929,000 73,964,000 22,016,000
Mar 2026 2,772,000 — -25,375,000 -22,253,000 397,654,000 241,777,000 18,533,000
Dec 2025 3,078,000 — -28,423,000 -25,943,000 294,889,000 188,888,000 22,838,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-87,601,000
Investing CF
$-212,854,000
Financing CF
$154,150,000
CapEx
$-488,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.26
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-381,766,000
Inventory
—
Receivables
$625,000
ST Investments
$244,781,000
EBIT TTM
$-94,183,000
Pretax Income TTM
$-94,464,000
Interest Exp TTM
$281,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,599,000
EBITDA
$-120,260,000
Free Cash Flow
$-71,778,248
Enterprise Value
$-35,488,560
Total Cash
$283,636,992
Total Debt
$2,730,000
Shares Out
45,951,078
Trailing EPS
$-2.56
Book Value
$7.54
ROE
-34.6%
ROA
-22.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 8,995,000 -92,780,000 -80,605,000 294,889,000 22,838,000 272,051,000 -81,627,000
Dec 2024 0 -78,194,000 -71,109,000 358,234,000 35,107,000 323,127,000 -51,522,000
Dec 2023 0 -48,400,000 -63,854,000 25,924,000 199,320,000 -173,396,000 -37,362,000
Dec 2022 0 -39,969,000 -39,722,000 28,429,000 140,988,000 -112,559,000 -36,181,000

TTM Snapshot

Revenues TTM
$10,355,000
NetIncome TTM
$-94,464,000
OpCashFlow TTM
—
Assets (Latest)
$396,929,000
Forward EPS
$-2.50

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $7.50 · spot: $4.77 · call volume: 14 · put volume: 101
Expected Move to 2027-01-15: ±$1.45 (30.40%) — implied range $3.32 – $6.22 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
FTH Faeth Therapeutics, Inc. $233.63M $9.04 —
RCKT ROCKET PHARMACEUTICALS, INC. $235.60M $2.11 —
VNDA Vanda Pharmaceuticals Inc. $230.39M $3.81 —
ARCT Arcturus Therapeutics Holdings Inc. $229.72M $7.97 —
LFCR LIFECORE BIOMEDICAL, INC. \DE\ $242.22M $6.39 —

News headlines (Yahoo Finance, 1h cache)

BioAge Labs to Present at Upcoming Investor Conferences
2026-11-11 13:00 · Yahoo
BioAge Labs, Inc. (BIOA) Reports Q3 Loss, Misses Revenue Estimates
2026-11-05 21:45 · Yahoo
BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates
2026-11-05 21:30 · Yahoo
Earnings Preview: BioAge Labs, Inc. (BIOA) Q3 Earnings Expected to Decline
2026-10-29 13:00 · Yahoo
Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
2026-10-14 12:00 · Yahoo
BioAge Labs' Lead Drug Faces Uncertain Path as Data Looms, UBS Says
2026-10-12 17:02 · Yahoo
BioAge Labs, Inc. (BIOA) Reports Q2 Loss, Beats Revenue Estimates
2026-08-06 00:35 · Yahoo
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-08-05 20:50 · Yahoo
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection?
2026-07-31 21:56 · Yahoo
BioArctic collaborator Novartis terminates agreement
2026-11-02 21:36 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.